This year's top USPSTF stories: Hormone therapy, aspirin for CVD prevention, sleep apnea
Click Here to Manage Email Alerts
Over the past year, the U.S. Preventive Services Task Force has released recommendations on screening and preventive treatment for various medical conditions
One of Healio’s most popular USPSTF stories of 2022 is about guidance on the use of hormone therapy for the primary prevention of chronic conditions in women after menopause. The recommendations advocate against the use of menopausal hormone therapy (MHT) through a combination of estrogen and progestin in postmenopausal people, and MHT through estrogen alone in postmenopausal people who have had a hysterectomy.
Other popular stories include a final recommendation advising against the initiation of aspirin for primary CVD prevention in older adults and the lack of evidence on the risks and benefits of sleep apnea screening in asymptomatic adults.
Catch up on Healio’s coverage of the USPSTF’s recommendations below:
USPSTF advises against hormone therapy to prevent chronic conditions after menopause
The USPSTF has released two final recommendations on the use of hormone therapy for the primary prevention of chronic conditions in postmenopausal people. Read more.
USPSTF finalizes recommendations on initiating aspirin for primary CVD prevention
The USPSTF has published a final recommendation that advises against the initiation of low-dose aspirin for primary CVD prevention in adults aged 60 years or older, a D-grade recommendation. Read more.
USPSTF: Evidence insufficient on risks, benefits of sleep apnea screening
There is still not enough evidence to make a recommendation for or against obstructive sleep apnea screening in asymptomatic adults, according to a statement from the USPSTF. Read more.
USPSTF releases draft recommendation on skin cancer screening in adults, adolescents
The USPSTF has released a draft recommendation stating there is not enough evidence to advocate for or against skin cancer screening in asymptomatic adults and adolescents. Read more.
USPSTF: No benefit of beta carotene, vitamin E, multivitamins in CVD, cancer prevention
The USPSTF issued a recommendation statement against the use of beta carotene or vitamin E supplements for the prevention of CVD or cancer. Read more.
USPSTF lacks evidence to make recommendation on atrial fibrillation screening.
The USPSTF said there is insufficient evidence to recommend atrial fibrillation screening for adults aged 50 years or older without a diagnosis or symptoms and no history of transient ischemic attack or stroke. Read more.
USPSTF finalizes recommendations on anxiety, depression, suicide risk screening in youth
The USPSTF has released final recommendation statements on anxiety, depression and suicide risk screening in children and adolescents. Read more.
USPSTF reaffirms syphilis screening recommendation
Citing an increase in the incidence of syphilis infections over the past 2 decades, the USPSTF has reaffirmed its recommendation to screen those at increased risk for infection. Read more.
USPSTF: Screen all adults aged younger than 65 years for anxiety
The USPSTF has released a historic draft recommendation statement, advocating for screening adults aged younger than 65 years for anxiety. Read more.
USPSTF finalizes recommendation on prediabetes, type 2 diabetes screening in youth
The USPSTF has published a final recommendation in JAMA, stating there is insufficient evidence to assess the benefits and harms of prediabetes and type 2 diabetes screening in asymptomatic children and adolescents. Read more.